American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Session Code: PS305
Title: Controversies and the Appropriate Incorporation of Emerging Technologies in Multidisciplinary Treatment of Liver and Pancreatic Cancer
Date and Time of Session: Wednesday, October 25: 8:00 am - 9:30 am
Description: Advances in technology and innovation are key drivers to move clinical practice forward. Novel treatment modalities have emerged in the surgical management of liver and pancreas cancer including minimally invasive surgery (MIS), associating liver partition and portal vein ligation (ALPPS) for staged hepatectomy, and irreversible electroporation (IRE). As these techniques are developed and promoted, surgeons need to assess their efficacy and safety and introduce them into practice carefully. Key questions addressed by the panel will include: Optimal introduction of these novel techniques into clinical practice? Participation in current and future clinical trials and device registries? Challenges of adopting novel treatment modalities in the United States and internationally?
CME Credit Hours: 1.5
Webcast Package Available: Yes
Audio Package Available: Yes
Track:
General Surgery (GEN), Surgical Oncology (ONC)
Credit to Address Regulatory Mandates:
Patient safety
Credit to Address ACS Accreditation/Verification Requirements:
Cancer,
Sponsored By:
International Relations Committee, CRP Education Committee
Program Participants:
Moderator
Clancy J. Clark, MD FACS
Co-Moderator
George John Tsioulias, MD FACS
Speaker Introduction
George John Tsioulias, MD FACS
Speaker Past, Present, and Future of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS)
Eduardo De Santibañes , MD Phd FACS (Hon)
Speaker Learning Curve, Training, and Opportunities for Innovation in Robotic Pancreatic Surgery
Herbert J. Zeh, III, MD FACS
Speaker Registries, Clinical Trials, and Adoption of Institutional Review Board (IRB) into Clinic Practice
Robert C. G. Martin, MD, PhD, FACS
Speaker Closing Remarks and Panel Discussion
Clancy J. Clark, MD FACS